1. Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93.
- Author
-
Huang J, Lee HY, Zhao X, Han J, Su Y, Sun Q, Shao J, Ge J, Zhao Y, Bai X, He Y, Wang X, Wang X, and Dong C
- Subjects
- Animals, Cell Line, Colitis immunology, Colon immunology, Epithelial Cells immunology, Interleukins immunology, Male, Mice, Mice, Inbred C57BL, RAW 264.7 Cells, Interleukin-22, Immunity, Innate immunology, Interleukin-27 immunology, Lymphocytes immunology, Membrane Glycoproteins immunology
- Abstract
The interleukin (IL)-17 family, consisting of six members, promotes host defense but can in some context promote the development of autoimmune disease. Here, we examined the role of IL-17D, a poorly understood member in the IL-17 family. IL-17D was expressed primarily by colonic epithelial cells. Il17d
-/- mice were more susceptible to acute colitis, bacterial infection and experimentally induced colon cancer than their wildtype counterparts. Il17d deficiency impaired IL-22 production by group 3 innate lymphoid cells (ILC3s) and reduced expression of IL-22-dependent antimicrobial peptides, RegIIIβ and RegIIIγ, in colon tissue at steady state and in colitis; this was associated with changes in microbial composition and dysbiosis. Protein purification studies revealed that IL-17D bound not canonical IL-17 receptors, but rather CD93, a glycoprotein expressed on mature ILC3s. Mice lacking Cd93 in ILC3s exhibited impaired IL-22 production and aggravated colonic inflammation in experimental colitis. Thus, an IL-17D-CD93 axis regulates ILC3 function to preserve intestinal homeostasis., Competing Interests: Declaration of interests J.L.H., X.H.W., and C.D. have filed a provisional patent disclosure based on the results in the paper., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF